47
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.

      Science (New York, N.Y.)
      Adenosine Triphosphate, metabolism, Cell Division, Citric Acid Cycle, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Glucose, Glutamine, Glycolysis, Humans, NADP, Neoplasms, drug therapy, genetics, pathology, Oncogenes, Pentose Phosphate Pathway, Signal Transduction

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cells from some tumors use an altered metabolic pattern compared with that of normal differentiated adult cells in the body. Tumor cells take up much more glucose and mainly process it through aerobic glycolysis, producing large quantities of secreted lactate with a lower use of oxidative phosphorylation that would generate more adenosine triphosphate (ATP), water, and carbon dioxide. This is the Warburg effect, which provides substrates for cell growth and division and free energy (ATP) from enhanced glucose use. This metabolic switch places the emphasis on producing intermediates for cell growth and division, and it is regulated by both oncogenes and tumor suppressor genes in a number of key cancer-producing pathways. Blocking these metabolic pathways or restoring these altered pathways could lead to a new approach in cancer treatments.

          Related collections

          Author and article information

          Comments

          Comment on this article